A historic shift in our drug policy has occurred, as the regulators allow the use of psilocybin hallucinogens for therapeutic applications. Before this, these substances were strictly restricted, but a growing body of research suggests they may offer aid for emotional conditions like PTSD. The new policy represents a key step toward rethinking Cana